Skip to main content

Sarfraz Ahmad, PhD; FAACC; FABAP

Sarfraz Ahmad , PhD; FAACC; FABAP

Director, Clinical Research at Gynecologic Oncology

Cancer

Sarfraz Ahmad

Overview

Dr. Ahmad is Director of Clinical Research at Gynecologic Oncology Program of AdventHealth Cancer Institute (AHCI), Orlando. Before joining AHCI in 2002, he spent 10-years in research and teaching at Loyola University of Chicago and University of Illinois at Chicago’s Division of Hematology/Oncology, College of Medicine. He has trained several fellows, residents, medical students, and graduate/undergraduate students during their research projects. He is also Professor of Medical Education at University of Central Florida and Professor of Clinical Sciences at Florida State University, Colleges of Medicine, Orlando. His current research focus is on the analysis of clinico-pathologic and surgical outcomes of gynecology/oncology patients and to understand the cellular/molecular mechanisms of cancer and related thromboembolic/hematologic disorders. His investigations are also aimed towards the evaluation of novel treatment options (chemo/cellular/immuno-therapies) for better management of hemato-oncologic patients. His past research interests focused on the anticoagulant, antithrombin, antiplatelet, and thrombolytic drug development for the management of hematologic and cardiovascular patients. In these various areas of biomedical research, Dr. Ahmad has published nearly 300 peer-reviewed scholarly research articles and book chapters, and over 450 scientific abstracts. He is a reviewer for several biomedical journals and has received several competitive research grants and national/international awards for his research accomplishments/contributions. Dr. Ahmad is also passionate about classical Hindi-Urdu literature & poetry and takes pride with active participation in such forums.

Articles

Role of biosimilar pegfilgrastim in the treatment of febrile neutropenia: A Mini Review

INDIAN JOURNAL OF BIOCHEMISTRY & BIOPHYSICS

2024

Plastic orchiectomy and some indicators of improvement of vital parameters and general condition of the organism in blood of the men with prostate cancer

INDIAN JOURNAL OF BIOCHEMISTRY & BIOPHYSICS

2024

Assessing the protective effects of chard on valproic acid-induced pancreatic complications

INDIAN JOURNAL OF BIOCHEMISTRY & BIOPHYSICS

2024

Fatty acid synthase: A key driver of ovarian cancer metastasis and a promising therapeutic target

PATHOLOGY RESEARCH AND PRACTICE

2024

Neoadjuvant chemotherapy with bevacizumab for locally advanced vulvar cancer

INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER

2024

Association of chondroadherin with leiomyosarcoma

GYNECOLOGIC ONCOLOGY REPORTS

2023

Rapid recurrence of stage IIB non-gestational ovarian choriocarcinoma with minor yolk sac tumor: A rare case report and literature review

GYNECOLOGIC ONCOLOGY REPORTS

2023

Emerging role of biosimilars: Focus on trastuzumab and metastatic human epidermal growth factor receptor 2-positive breast cancer

RESULTS IN CHEMISTRY

2023

Standardized Titration Protocol Reduces the Incidence of Paclitaxel Infusion-Related Hypersensitivity Reactions

JCO ONCOLOGY PRACTICE

2023

Prognostic features of the tumor microenvironment in high-grade serous ovarian cancer and dietary immunomodulation

LIFE SCIENCES

2023

Education & Training

Education

North Eastern Hill University

Specialty

Clinical Research